Ownership history in UBS Group AG · 5 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CAN FITE BIOFARMA LTD (CANF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 20,942 | +19,634 | +1501.1% | 0.00% | $4K | $4.00 |
| 2025 Q3 | REDUCED | 1,308 | -4,207 | -76.3% | 0.00% | $810 | $12.40 |
| 2025 Q2 | ADDED | 5,515 | +3,343 | +153.9% | 0.00% | $6K | $21.00 |
| 2024 Q1 | ADDED | 2,172 | +1,458 | +204.2% | 0.00% | $5K | $44.40 |
| 2023 Q1 | INITIATED | 714 | — | — | 0.00% | $2K | $45.80 |
As of 2025 Q4 — sorted by position size